Page results
-
The Neuroimmunology and CSF Laboratory at the Institute of Neurology, UCLH is a UKAS accredited medical laboratory No. 8045.
-
The first UK trial to test the benefits of proton beam therapy for certain patients with breast cancer has launched at UCLH.
-
Bones marrow harvest patient information page.
-
This service provides a tertiary level, second opinion service, specialising in the diagnostic assessment and treatment of complex speech sound disorders. The team has particular expertise in Childhood Apraxia of Speech (CAS).
-
This is information for women who have been given a diagnosis of adenomyosis.
-
Once again, UCLH has received the highest score of all general acute and acute/community NHS trusts in England for staff that would recommend us as a place to work
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy).
-
Our annual members' meeting (AMM) brings together members, governors and staff, and is where our governors officially receive our annual report and accounts.
-
Health and wellbeing information for people affected by cancer.
-
This information aims to support and supplement the information provided in the Be Active video available on uclh.nhs.uk/wellbeing
File results
-
FOI/2023/0455 - NHS remediating elective surgery operations
-
FOI/2023/0453 - Patient transport home bookings
-
FOI/2023/0452 - Eating disorders
-
FOI/2023/0246 - Digital services used for patient care
-
FOI/2023/0750 - Treatment for non-small cell lung cancer
-
FOI201746 Contact details for the IT integration manager
-
FOI201749 Contact details for heads of midwifery, neonatal services, bereavement services
-
FOI201753 Female genital mutilaton
-
FOI/2023/0614 - Communications
-
FOI201779 Arthritis treatments for patients